HIV Treatment Bulletin
May news – April news – March news – All back issues
HIV Treatment Bulletin (HTB) is a community publication that has critically reported on advances in HIV research since April 2000.
HTB is distributed in electronic formats.
ISSN 1472-4863.
Featured reports
- UK PrEP booklets now available
- IAS 2025: WHO guidelines: major updates on injectables, AHD, breastfeeding, infant prophylaxis and peer support
- AIDS quilts at the Tate: reflection and call for action
- UK HIV care for transgender and non-binary people: EHRC guidance is unworkable
- Latest news on the US crisis and its impact on global health
- Reduced dosing: a possible crisis response to ART stockouts and closed clinics
Early access
- Liverpool University launches new PrEP drug interaction website: covers oral, injectable and ring-based PrEP
- Long-lived macrophages might explain unsuppressible low-level viraemia on ART
- CROI 2026: Nine comprehensive free reviews in Topics in Antiviral Medicine
- Transgender health in Australia: HIV drops by 94% as PrEP increases over 10 years
- BHIVA 2026: HIV and neurodiversity includes higher concerns over adherence
- US FDA and Japan approve new once-daily oral HIV combination of doravirine/islatravir (IDVYNSO)
- US CDC stops testing services for key infectious diseases: rabies, mpox, measles, EBV, SARS and others
- Psilocybin is 6-fold more effective than nicotine patches to stop smoking in pilot US study with CBT
- Update on Gilead’s once-weekly oral HIV GS-1720 and GS-4182 studies
- Two cases of severe hyperglycemia with injectable CAB/RPV-LA